Introduction and objectives: The mechanisms by which PGE 1 suppresses transforming growth factor b 1 (TGF-b 1 ) induced ®brillar collagen synthesis in human corpus cavernosum smooth muscle cells (HCC SMC) remain unde®ned. Since PGE 1 induces cyclic AMP (cAMP) synthesis in HCC SMC, the aim of this research is to investigate the role of cAMP in the regulation of connective tissue biosynthesis in human corporal smooth muscle cells in culture.
Introduction
The trabeculae of the corpora cavernosa consist primarily of connective tissue and smooth muscle components which both play critical roles in normal penile erection. 1±3 Following sexual stimulation, endothelial and neurogenic mediated factors induce trabecular smooth muscle relaxation, enabling blood to ®ll lacunar spaces and increase intracavernosal volume and pressure. Connective tissue accounts for $ 55% of the overall erectile tissue content 1, 3 and provides structural integrity to the corpora cavernosa. The erectile tissue is suf®ciently expandable during erection to apply stretching and compressive forces on subtunical venules to achieve adequate venous out¯ow resistance and corporal veno-occlusion.
1±3
Erectile dysfunction follows abnormalities affecting both trabecular smooth muscle and connective tissue components. 1±3 In particular, collagen accumulation in the trabeculae has been associated with failure of the veno-occlusive mechanism. 3 In a recent prospective human corporal structure-function study, veno-occlusive dysfunction was noted when trabecular connective tissue per total erectile tissue content was greater than $ 65% and parameters of veno-occlusive function worsened in severity as the percent trabecular connective tissue content increased. 3 Vasculogenic erectile dysfunction secondary to structural-based corporal venoocclusive dysfunction has been shown to be the major pathophysiology resulting in treatment failures of the various pharmacologic therapies and the eventual need for penile prosthesis insertion.
Research in pathophysiology of erectile dysfunction has focused primarily on the trabecular smooth muscle component, in particular, mechanisms regulating smooth muscle function and tone. 1 There have been limited investigations concerning factors which regulate trabecular connective tissue metabolism. Among the factors that could potentially regulate trabecular connective tissue synthesis and degradation are transforming growth factor b 1 (TGFb 1 ) and prostaglandin E 1 (PGE 1 ). 4 TGF-b 1 is a pleiotropic cytokine which induces connective tissue expression and inhibits growth of vascular smooth muscle cells. 4 TGF-b 1 has been shown to alter the composition of extracellular matrix by inducing expression of collagens, ®bronectin and proteoglycans while inhibiting the activity and expression of collagenases and other proteases. 5 We have shown that in human corpus cavernosum smooth muscle cells (HCC SMC) TGF-b 1 induces ®brillar collagen synthesis, while PGE 1 suppresses this TGF-b 1 -induced collagen synthesis. 4 The intracellular pathways by which trabecular collagen metabolism is regulated remain unde®ned. Trabecular smooth muscle tone is mediated via the second messengers, cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP).
1,2 PGE 1 binds to speci®c PGE (EP) receptors on the trabecular smooth muscle cell membrane increasing intracellular cAMP synthesis. 1, 2 This increase ultimately results in trabecular smooth muscle relaxation. Since PGE 1 suppresses TGF-b 1 -induced ®brillar collagen synthesis, it is postulated that the suppressive effect of PGE on collagen synthesis is probably mediated by increased intracellular cAMP. In this report, we investigated if the intracellular factors which regulate trabecular smooth muscle tone also modulate trabecular connective tissue biosynthesis. The overall aim of this research is to investigate the intracellular pathways regulating biosynthesis of trabecular connective tissue, in particular, the roles of cyclic nucleotides. Such information is critical for improving our knowledge of the pathophysiology of structuralbased corporal veno-occlusive dysfunction.
Materials and methods
Collagen synthesis in human corpus cavernosum smooth muscle cell culture Human corpus cavernosum smooth muscle cells were prepared as previously reported. 4 Human corpus cavernosa were obtained as sterile surgical specimens at the time of penile prosthesis insertion. Cells from four different patients were examined in this study. These patients ranged in age from 24± 66 y of age and had a wide range of etiologies. These included diabetes, hypertension, crural trauma, and peripheral vascular disease. All of these patients had failed injection therapy. This study was approved by the Institutional Review Board at Boston University Medical Center. Cells were grown to con¯uence in Dulbecco's modi®ed Eagle's medium with 5.5 mM glucose (DMEM) supplemented with 25 U/ml penicillin, 250 U/ml streptomycin, 25 U/ml nystatin, 2 mM glutamine, and 1 mM nonessential amino acids (all from GIBCO-BRL, Grand Island, NY) and 10% fetal bovine serum (Summit Biotechnology, Greene, CO). All cultures used in this study were passage 1±3. The cells were re-fed the same media except that the serum concentration decreased to 0.4% fetal bovine serum and the cells incubated for 24 h. The media were removed and the cells were re-fed with the same media supplemented with 0.4% fetal bovine serum, 50 mg/ml ascorbate (a cofactor for prolyl hydroxylase), 50 mg/ml b-aminoproprionitrile (b-APN, an inhibitor of collagen crosslinking) and 2 mCi/ml of [ 3 H]proline. At the end of the incubation, the media were removed, protease inhibitors (0.2 mM phenylmethylsulphonyl¯uoride (PMSF) and 2 mM EDTA) were added, the media acidi®ed with acetic acid (®nal concentration 0.5 N) and digested for 6±12 h with 1 mg/ml pepsin at 2 C. Aliquots were removed and proteins precipitated with ice-cold 10% trichloroacetic acid (TCA). The precipitates were redissolved in 0.5 ml 1 N NaOH and neutralized with 0.5 ml of 1 N HCl before the addition of liquid scintillation¯uid (Liquiscint; National Diagnostics, Raritan, NJ). Samples were counted for radioactivity. Cells were scraped in a lysis buffer (50 mM TRIS-Cl, 2 mM EDTA, 1 M NaCl pH 7.40 containing 0.2 mM PMSF).
Cells were homogenized by passage three times through a 22 gauge needle. This material was acidi®ed with acetic acid (®nal concentration 0.5 N), and digested for 6±12 h with 1 mg/ml pepsin at 2 C. Aliquots were removed and proteins precipitated with ice-cold 10% TCA. These samples were counted for radioactivity.
Cell number was determined in parallel dishes of cells using a hemacytometer. All data points were corrected for background. Duplicate and triplicate samples were averaged and expressed as normalized pepsin resistant decays per minute (DPM)/million cells. We have previously reported that pepsin resistant material consists of ®brillar collagen (types I, III, and V/XI) when examined by SDS-polyacrylamide gel electrophoresis in the presence and absence of collagenase. 4 In this report, we refer to pepsin resistant, TCA precipitated material as collagen.
Collagen synthesis was performed in the presence and absence of the following agents: 3-isobutyl-1-methylxanthine (IBMX), sodium nitroprusside, zaprinast, N 
Assay of cAMP in tissue culture cells
Radioimmunoassays for cAMP were carried as previously described. Cyclic GMP To determine if cGMP had an effect on TGF-b 1 -induced collagen synthesis, HCC SMC were treated with TGF-b 1 in the absence or presence of the nitric oxide donor, sodium nitroprusside. As shown in Figure 2 (dark bars), treatment with sodium nitroprusside had no effect on TGF-b 1 -induced collagen synthesis. Treatment with the type 5 selective phosphodiesterase inhibitor zaprinast which inhibits cGMP hydrolysis in these cells, had no effect on sodium nitroprusside treatment of TGF-b 1 -induced collagen synthesis (Figure 2a , open bars, 30 mM zaprinast). In order to verify this observation, cells were treated with TGF-b 1 with and without a cell permeable analogue, dibutyryl cGMP. Treatment with 300 mM dibutyryl cGMP had no effect on TGF-b 1 -induced collagen synthesis (Figure 2b ).
Discussion
The trabecular connective tissue provides an internal structural support to the corpora cavernosa during penile erection. Although research on the trabecular connective tissue component has been limited compared to that of the smooth muscle constituent, considerable progress has been made. Trabecular smooth muscle cells produce connective tissue. 4 HCC SMC in culture synthesize type I, III, and V/XI ®brillar collagens and TGF-b 1 induces ®brillar collagen synthesis in HCC SMC. 4 Further, TGF-b 1 autoinduces its own synthesis by increasing expression of TGF-b 1 mRNA in HCC SMC and TGFb 1 induces expression of all three types of TGF-b receptors in HCC SMC.
3,4 PGE 1 suppresses TGF-b 1 -induced type I, III, and V/XI ®brillar collagens in HCC SMC. 4 The goal of this study was to expand our understanding of the biosynthesis of trabecular connective tissue by investigating the intracellular factors regulating its metabolism.
In this report, we demonstrated that cAMP modulates TGF-b 1 -induced collagen synthesis in human corpus cavernosum smooth muscle cells. Agents which increased intracellular cAMP synthesis by different mechanisms 1,2,6,7 suppressed TGFb 1 -induced collagen synthesis. PGE 1 elevates cAMP synthesis in HCC SMC by binding to EP2 and/or EP4 cell surface receptors 2, 6, 7 which transduce their signal via coupling to a Gs-protein mechanism thereby indirectly activating adenylate cyclases. 1, 2, 6, 7 Forskolin, on the other hand, increases cAMP synthesis in HCC SMC by direct activation of adenylate cyclase. Both of these cAMP enhancing agents, independent of their mechanism of adenylate cyclase activation, suppress TGF-b 1 -induced collagen synthesis. We further noted that the membrane-permeable cAMP analogue, dibutyryl cAMP, inhibited TGF-b 1 -induced collagen synthesis. These data are in agreement with those from fetal lung ®broblasts in which increases in cAMP levels inhibit both basal collagen 8, 9 as well as TGFb 1 -induced collagen synthesis. 10 These results suggest that inhibition of TGF-b 1 -induced collagen synthesis proceeds through a cAMP-dependent pathway and that agents which relax trabecular smooth muscle and increase cAMP synthesis also inhibit TGF-b 1 -induced collagen synthesis.
Cyclic AMP activates both protein kinase A and protein kinase C mechanisms. 11 Protein kinase A phosphorylates a number of cytosolic and nuclear substrates; among them the cyclic AMP responsive element binding proteins (CREB). 11 Protein kinase C phosphorylates the kinases in the mitogen activated protein kinase cascade eventually activating other transcription factors in the nucleus. The pathways involved in cAMP-mediated suppression of TGF-b 1 -induced collagen synthesis remain to be determined.
Cyclic GMP did not modulate TGF-b 1 -induced collagen synthesis. Sodium nitroprusside, a nitric oxide donor which increases cGMP synthesis, had no effect on TGF-b 1 -induced collagen synthesis. Sodium nitroprusside (10 mM) has been previously shown to relax human corpus cavernosum muscle strips in organ baths, as well as activate HCC SMC Na K ATPase activity 12 and increase cGMP levels 1.8 fold in the presence of 30 mM zaprinast. 13 Treatment with a selective phosphodiesterase type 
Conclusions
We have demonstrated that cAMP inhibits TGF-b 1 -induced collagen synthesis in HCC SMC. Pharmacologic strategies which increase trabecular smooth muscle cAMP either through speci®c G-proteincoupled receptors, direct stimulation of adenylate cyclase or inhibition of phosphodiesterase activity may have bene®cial prophylactic effects as modulators of corpora cavernosal trabecular connective tissue biosynthesis. cAMP modulation of trabecular smooth muscle collagen synthesis RB Moreland et al
